Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Natalizumab drug holiday in multiple sclerosis: poorly tolerated.
Killestein J, Vennegoor A, Strijbis EM, Seewann A, van Oosten BW, Uitdehaag BM, Polman CH. Killestein J, et al. Among authors: strijbis em. Ann Neurol. 2010 Sep;68(3):392-5. doi: 10.1002/ana.22074. Ann Neurol. 2010. PMID: 20661928
Blood platelet RNA enables the detection of multiple sclerosis.
Sol N, Leurs CE, Veld SGI', Strijbis EM, Vancura A, Schweiger MW, Teunissen CE, Mateen FJ, Tannous BA, Best MG, Würdinger T, Killestein J. Sol N, et al. Among authors: strijbis em. Mult Scler J Exp Transl Clin. 2020 Jul 30;6(3):2055217320946784. doi: 10.1177/2055217320946784. eCollection 2020 Jul-Sep. Mult Scler J Exp Transl Clin. 2020. PMID: 32843989 Free PMC article.
Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis.
Nauta IM, Kulik SD, Breedt LC, Eijlers AJ, Strijbis EM, Bertens D, Tewarie P, Hillebrand A, Stam CJ, Uitdehaag BM, Geurts JJ, Douw L, de Jong BA, Schoonheim MM. Nauta IM, et al. Among authors: strijbis em. Mult Scler. 2021 Oct;27(11):1727-1737. doi: 10.1177/1352458520977160. Epub 2020 Dec 9. Mult Scler. 2021. PMID: 33295249 Free PMC article.
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
van Lierop ZY, Toorop AA, van Ballegoij WJ, Olde Dubbelink TB, Strijbis EM, de Jong BA, van Oosten BW, Moraal B, Teunissen CE, Uitdehaag BM, Killestein J, Kempen ZLV. van Lierop ZY, et al. Among authors: strijbis em. Mult Scler. 2022 Jun;28(7):1121-1125. doi: 10.1177/13524585211028833. Epub 2021 Jul 9. Mult Scler. 2022. PMID: 34240631 Free PMC article.
32 results